{"id":29711,"date":"2025-11-02T00:13:08","date_gmt":"2025-11-02T00:13:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/us-fl\/29711\/"},"modified":"2025-11-02T00:13:08","modified_gmt":"2025-11-02T00:13:08","slug":"entero-regains-nasdaq-compliance-with-grid-ai-acquisition","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us-fl\/29711\/","title":{"rendered":"Entero Regains Nasdaq Compliance With Grid AI Acquisition"},"content":{"rendered":"

BOCA\u202fRATON, FL \/ ACCESS Newswire<\/a> \/ October 30, 2025 \/ Entero Therapeutics, Inc. (\u201cEntero\u201d or the \u201cCompany\u201d) (NASDAQ:ENTO) is pleased to announce that, as a result of the acquisition of 100% of Grid AI Corp. (\u201cGrid AI\u201d), it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the \u201cEquity Rule\u201d).<\/p>\n

Entero\u2019s publicly\u2011listed platform now sits at the intersection of AI, data centers, power grids, and global infrastructure. The acquisition of Grid\u202fAI, now operating as a wholly\u2011owned subsidiary of Entero, enables the Company to participate in one of the most significant secular growth arenas of the coming decade: hyperscale data centers, grid\u2011edge orchestration, and AI\u2011driven infrastructure optimization.<\/p>\n

Forward\u2011Looking Statements
This press release contains forward\u2011looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the strategic benefits of the acquisition, the integration of Grid\u202fAI, the ability to maintain compliance with Nasdaq\u2019s listing criteria in connection with the Grid AI acquisition and otherwise, the ability to obtain shareholder approval of the common stock underlying the preferred stock issued in the Grid AI acquisition, expected future operating results, market opportunities, and the Company\u2019s growth strategy. Actual results may differ materially due to risks and uncertainties. The Company undertakes no obligation to update forward\u2011looking statements except as required by law.<\/p>\n

About Entero Therapeutics, Inc.
Entero Therapeutics (NASDAQ:ENTO) is a publicly listed company. The Company\u2019s programs address significant unmet needs in gastrointestinal (GI) health and comprise development of Adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency. Following the acquisition of Grid\u202fAI, the Company is continuing these prior operations and is also repositioning into the infrastructure, AI and data\u2011centre orchestration space. Entero operates Grid\u202fAI as a wholly\u2011owned subsidiary and intends to leverage its public\u2011market listing and corporate resources to scale the new venture.<\/p>\n

About Grid\u202fAI
Grid\u202fAI is an AI\u2011driven, grid\u2011edge software and device orchestration platform enabling business, utility, and hyperscaler customers to forecast, optimize, and dispatch flexible demand, DERs and compute assets. The platform supports major ML frameworks, offers rapid scale across cloud GPU\/CPU infrastructure, and is designed to deliver SaaS\u2011like recurring revenue.<\/p>\n

Investor & Media Contacts:
Entero Investor Relations
investors@enterothera.com<\/a><\/p>\n

SOURCE: Entero Therapeutics, Inc.<\/p>\n

<\/p>\n

View the original press release<\/a> on ACCESS Newswire<\/p>\n

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media<\/p>\n","protected":false},"excerpt":{"rendered":"BOCA\u202fRATON, FL \/ ACCESS Newswire \/ October 30, 2025 \/ Entero Therapeutics, Inc. (\u201cEntero\u201d or the \u201cCompany\u201d) (NASDAQ:ENTO)…\n","protected":false},"author":2,"featured_media":17567,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[232,234,233],"class_list":["post-29711","post","type-post","status-publish","format-standard","has-post-thumbnail","category-tallahassee","tag-tallahassee","tag-tallahassee-headlines","tag-tallahassee-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/posts\/29711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/comments?post=29711"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/posts\/29711\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/media\/17567"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/media?parent=29711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/categories?post=29711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-fl\/wp-json\/wp\/v2\/tags?post=29711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}